CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 81 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,764,558 | +112.2% | 1,269,674 | +28.6% | 0.00% | +100.0% |
Q2 2023 | $17,794,575 | +16.0% | 987,490 | +3.4% | 0.00% | 0.0% |
Q1 2023 | $15,335,057 | +90866.1% | 954,860 | +3.7% | 0.00% | 0.0% |
Q4 2022 | $16,858 | -99.9% | 921,230 | +4.3% | 0.00% | -33.3% |
Q3 2022 | $17,343,000 | +9.3% | 883,095 | +3.8% | 0.00% | +50.0% |
Q2 2022 | $15,869,000 | -2.4% | 850,938 | +14.9% | 0.00% | 0.0% |
Q1 2022 | $16,251,000 | -18.1% | 740,385 | +6.0% | 0.00% | 0.0% |
Q4 2021 | $19,851,000 | +81.4% | 698,738 | +34.4% | 0.00% | +100.0% |
Q3 2021 | $10,945,000 | +14.1% | 519,997 | +2.2% | 0.00% | 0.0% |
Q2 2021 | $9,591,000 | +66.3% | 508,821 | +34.8% | 0.00% | 0.0% |
Q1 2021 | $5,767,000 | +27.1% | 377,434 | +17.4% | 0.00% | 0.0% |
Q4 2020 | $4,536,000 | -7.1% | 321,501 | +3.1% | 0.00% | 0.0% |
Q3 2020 | $4,885,000 | -11.9% | 311,777 | -1.5% | 0.00% | 0.0% |
Q2 2020 | $5,545,000 | +181.5% | 316,560 | +136.2% | 0.00% | 0.0% |
Q1 2020 | $1,970,000 | -69.4% | 134,019 | -47.8% | 0.00% | 0.0% |
Q4 2019 | $6,442,000 | +252.0% | 256,818 | +111.1% | 0.00% | – |
Q3 2019 | $1,830,000 | -38.8% | 121,678 | +1.8% | 0.00% | -100.0% |
Q2 2019 | $2,988,000 | +45.6% | 119,535 | +32.5% | 0.00% | 0.0% |
Q1 2019 | $2,052,000 | -54.8% | 90,192 | -40.4% | 0.00% | 0.0% |
Q4 2018 | $4,536,000 | +163.4% | 151,306 | +151.7% | 0.00% | – |
Q3 2018 | $1,722,000 | – | 60,115 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |